NCT07071688View on ClinicalTrials.gov

Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy

Not yet recruitingOBSERVATIONAL
Enrollment

338

Participants

Timeline

Start Date

July 20, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
TumorRadiotherapyBiomarker
Trial Locations (3)

Guangdong 510515

Nanfang hospital, Southern medical university, Guangzhou, Guangdong 510515, Guangzhou

Unknown

Huizhou Central People's Hospital, Huizhou, Huizhou

Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou,, Meizhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER